Intravascular squamous cell carcinoma treated with cemiplimab
Saved in:
Main Authors: | Alexander N. Rose, BS (Author), Emrullah Yilmaz, MD, PhD (Author), John R. Durkin, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid response to cemiplimab for advanced cutaneous squamous cell carcinoma
by: Hanieh Zargham, MD, et al.
Published: (2022) -
Metastatic cutaneous squamous cell carcinoma responsive to cemiplimab in a patient with multiple myeloma
by: Nareh Valerie Marukian, MD, et al.
Published: (2020) -
Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma
by: Cesar A. Virgen, MD, PhD, et al.
Published: (2020) -
Recurrent bilateral cutaneous squamous cell carcinoma arising within hypertrophic lichen planus with metastasis while on cemiplimab
by: Melissa C. Leeolou, BS, et al.
Published: (2022) -
Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
by: Jacob D. Siegel, MD, et al.
Published: (2021)